Rare diseases
Investigational molecules
Locations
2882 Sand Hill Road Suite 106, 94025-7057, United States
Summit Therapeutics Inc. focuses on advanced non-small cell lung cancer, including metastatic non-squamous NSCLC and disease that has progressed after prior systemic treatment. Its clinical portfolio includes patients with EGFR-mutant tumors and those whose cancer has advanced following EGFR tyrosine kinase inhibitor therapy.
The sponsor’s work in this area centers on treatment-resistant lung cancer populations with high unmet need.
Summit Therapeutics Inc. runs clinical trials in conditions such as Non-small cell lung cancer metastatic, Colorectal cancer metastatic, Transitional cell carcinoma, Transitional cell carcinoma metastatic, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Belgium
Spain
FranceBelgiumFranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
